Skip to main content
. 2019 Sep 26;2019(9):CD013438. doi: 10.1002/14651858.CD013438

Sharma 2018.

Methods RCT, parallel design
Participants Total number of randomized participants: 60
Inclusion criteria: either gender; 20‐50 years of age; ASA status I or II; scheduled for elective surgery under GA
Exclusion criteria: anticipated difficult airway; laryngoscopy time > 20 seconds; history of hypertension, diabetes, hepatic disease or renal disease; on preoperative beta‐blockers; pregnant or lactating women
Type of surgery: elective general surgery (types not specified ‐ we assumed non‐cardiac)
Baseline characteristics
Intervention group (esmolol)
  • Age, mean (SD): 30.86 (± 8.65) years

  • Gender, M/F: 18/12

  • ASA status I/II: 11/19


Control group (placebo)
  • Age, mean (SD): 31.46 (± 9.0) years

  • Gender, M/F: 21/9

  • ASA status: 10/20


Country: India
Setting: single centre; hospital
Interventions Intervention group (esmolol)
  • Randomized, n = 30; losses = 0; analysed, n = 30 (use of ITT analysis not reported)

  • Details: infusion of esmolol 1.5 mg/kg diluted in 20 mL normal saline before induction of anaesthesia


Control group (placebo)
  • Randomized, n = 30; losses = 0; analysed, n = 30

  • Details: 20 mL normal saline, given same as the intervention group

Outcomes Outcomes measured/reported by study authors: haemodynamic variables; myocardial insult (not defined); hypotension (not defined); bradycardia (not defined)
Outcomes relevant to the review: hypotension; bradycardia
Notes Funding/declarations of interest: no funding sources and study authors report no conflicts
Study dates: not reported
Note:
  • study includes an additional group (dexmedetomidine), which we did not include in the review

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Computer‐generated randomization, completed by anaesthetist who was not involved in drug administration or outcome assessment
Allocation concealment (selection bias) Low risk See above
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk Placebo‐controlled trial, anaesthetists not aware of group allocation
Blinding of outcome assessors (detection bias) 
 All outcomes Low risk Recordings made by a separate anaesthetist blinded to group allocation
Incomplete outcome data (attrition bias) 
 All outcomes Low risk No apparent losses
Selective reporting (reporting bias) Unclear risk Study authors did not report prospective clinical trial registration or publication of a protocol. It was not feasible to effectively assess risk of reporting bias
Other bias Low risk Not detected